Changing the course of diabetic nephropathy: Angiotensin-converting enzyme inhibition in type I diabetic renal disease

Marc A. Pohl, MD
Department of Nephrology and Hypertension, The Cleveland Clinic Foundation, Co-Investigator and Member of the Executive Committee, of the Collaborative Study Group